Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Apical membrane antigen 1: a malaria vaccine candidate in review.

Remarque EJ, Faber BW, Kocken CH, Thomas AW.

Trends Parasitol. 2008 Feb;24(2):74-84. doi: 10.1016/j.pt.2007.12.002. Review.

PMID:
18226584
2.

Apical membrane antigen 1 as an anti-malarial drug target.

Macraild CA, Anders RF, Foley M, Norton RS.

Curr Top Med Chem. 2011;11(16):2039-47. Review.

PMID:
21619512
3.

Nucleic acid malaria vaccines. Current status and potential.

Hoffman SL, Doolan DL, Sedegah M, Gramzinski R, Wang H, Gowda K, Hobart P, Margalith M, Norman J, Hedstrom RC.

Ann N Y Acad Sci. 1995 Nov 27;772:88-94. Review. No abstract available.

PMID:
8546416
4.

Immune responses to liver-stage parasites: implications for vaccine development.

Hollingdale MR, Krzych U.

Chem Immunol. 2002;80:97-124. Review. No abstract available.

PMID:
12058653
5.
6.

Genetic polymorphism in Plasmodium falciparum vaccine candidate antigens.

Mahajan RC, Farooq U, Dubey ML, Malla N.

Indian J Pathol Microbiol. 2005 Oct;48(4):429-38. Review.

PMID:
16366089
7.

Towards a blood-stage vaccine for malaria: are we following all the leads?

Good MF.

Nat Rev Immunol. 2001 Nov;1(2):117-25. Review.

PMID:
11905819
8.

Plasmodium falciparum serine repeat antigen 5 (SE36) as a malaria vaccine candidate.

Palacpac NM, Arisue N, Tougan T, Ishii KJ, Horii T.

Vaccine. 2011 Aug 11;29(35):5837-45. doi: 10.1016/j.vaccine.2011.06.052. Review.

PMID:
21718740
9.

Malaria and the immune system in humans.

Perlmann P, Troye-Blomberg M.

Chem Immunol. 2002;80:229-42. Review. No abstract available.

PMID:
12058641
10.

[Structural studies of malaria vaccine].

Tomita K.

Yakugaku Zasshi. 1992 Dec;112(12):873-86. Review. Japanese.

PMID:
1294714
11.

DNA vaccine against malaria: a long way to go.

Tuteja R.

Crit Rev Biochem Mol Biol. 2002;37(1):29-54. Review.

PMID:
11905546
12.

The immunological challenge to developing a vaccine to the blood stages of malaria parasites.

Good MF, Stanisic D, Xu H, Elliott S, Wykes M.

Immunol Rev. 2004 Oct;201:254-67. Review.

PMID:
15361246
13.

Asexual blood-stage malaria vaccine development: facing the challenges.

Genton B, Reed ZH.

Curr Opin Infect Dis. 2007 Oct;20(5):467-75. Review.

PMID:
17762779
14.

Variant antigen gene expression in malaria.

Dzikowski R, Templeton TJ, Deitsch K.

Cell Microbiol. 2006 Sep;8(9):1371-81. Review.

PMID:
16848786
15.

Antibodies to the circumsporozoite protein and protective immunity to malaria sporozoites.

Jones TR, Ballou WR, Hoffman SL.

Prog Clin Parasitol. 1993;3:103-17. Review. No abstract available.

PMID:
7678379
16.

Human immune responses against sexual stages of malaria parasites: considerations for malaria vaccines.

Mendis KN, David PH, Carter R.

Int J Parasitol. 1990 Jul;20(4):497-502. Review.

PMID:
2210943
17.

The future for blood-stage vaccines against malaria.

Richards JS, Beeson JG.

Immunol Cell Biol. 2009 Jul;87(5):377-90. doi: 10.1038/icb.2009.27. Review.

PMID:
19417768
18.

Vaccines against asexual stage malaria parasites.

Kumar S, Epstein JE, Richie TL.

Chem Immunol. 2002;80:262-86. Review. No abstract available.

PMID:
12058644
19.

[Biotechnological approaches to the creation of antimalarial vaccines].

Lalaiants IE, Milovanova LS.

Med Parazitol (Mosk). 1990 Jan-Feb;(1):53-7. Review. Russian.

PMID:
2191204
20.

Antigenic diversity, antigenic variation and merozoite surface protein 1.

Brown KN.

Parassitologia. 1993 Jul;35 Suppl:13-5. Review.

PMID:
8233603

Supplemental Content

Support Center